Blue Jet Healthcare Limited (IN:BLUEJET)
:BLUEJET
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹325.20 - ₹1,028.20
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹62.10B
Enterprise Value₹60.22B
Total Cash (Recent Filing)₹4.11B
Total Debt (Recent Filing)₹206.29M
Price to Earnings (P/E)57.2
Beta1.01
Next Earnings
May 25, 2026EPS Estimate
2.55Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)2.30
Shares Outstanding173,465,420
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)12.87
Price to Sales (P/S)14.16
P/FCF Ratio-427.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)25.37
Revenue Forecast (FY)₹11.97B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA sustained 45% revenue jump to ₹10,299m demonstrates durable commercial traction in APIs and custom synthesis. Strong top-line growth reflects expanding customer engagements and market penetration in regulated/semi-regulated markets, supporting scalable capacity utilization and long-term revenue visibility.
Margin SustainabilityHigh and improving gross and net margins indicate pricing power and operational efficiency consistent with specialty/niche API production. Robust EBIT/EBITDA margins suggest durable profitability, enabling reinvestment into capacity, quality systems, or niche R&D without eroding long-term margin structure.
Balance Sheet StrengthVery low leverage and a high equity ratio provide financial resilience and strategic optionality. Minimal debt reduces refinancing and covenant risk, while a strong ROE signals efficient capital use—together these factors support durable investment capacity and downside protection through cycles.
Bears Say
Weak Cash ConversionOperating cash covers only a small portion of reported earnings and FCF turned negative year-over-year, suggesting working-capital pressure or elevated capex. This undermines self-funding for growth, constrains capital returns, and poses a material liquidity risk over the next several months without corrective actions.
Business Model ConcentrationHeavy reliance on B2B API sales and contract manufacturing concentrates revenue and pricing exposure with a limited set of pharmaceutical customers. Contract renewals or pricing renegotiations can materially affect utilization and margins, creating structural revenue volatility absent broader customer or product diversification.
Limited Customer DisclosureLack of disclosed customer and segment-level detail creates opacity around concentration risk. Investors cannot gauge dependence on a few large counterparties, which raises the chance that loss or pricing pressure from a single customer could materially impact revenue and cash generation in the medium term.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹325.20 and its highest was ₹1028.20 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹62.10B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is May 25, 2026 which is in 47 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on Feb 13, 2026. The company reported ₹2.3 earnings per share for the quarter, missing the consensus estimate of ₹3.55 by -₹1.25.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.22%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate is 2.55.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 173,465,420 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹2.3 in its last earnings report, missing expectations of ₹3.55. Following the earnings report the stock price went down -9.998%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Jubilant Ingrevia Ltd.
―
Supriya Lifescience Limited
―
Syngene International Ltd.
―